Results

1–10 of 39 results for intravitreal injection

Agitation of the Syringe as a Cause of Inflammation After Intravitreal Injection of Aflibercept: A Randomized, Double-blind, Controlled Clinical Trial
Gustavo Barreto de Melo, MD, PhD, FASRS
Annual Meeting Talks
2020
Intravitreal Injection of Allogeneic Human Retinal Progenitor Cells for Treatment of Retinitis Pigmentosa: Results from the Phase 2b Trial
Anthony Joseph, MD
Annual Meeting Talks
2020
Particulate Matter From Syringes Used for Intravitreal Injections
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2020
Medicare 2012-2017 Intravitreal Injections: Certification and Credentials of Providers
Geoffrey G. Emerson, MD, PhD, FASRS
Annual Meeting Talks
2020
Cooling Anesthesia for Intravitreal Injection With a Novel Device: Results of the Prospective COOL-2 Study
Daniel L Chao, MD, PhD
Annual Meeting Talks
2020
Intravitreal Injections and Cataract Surgery Wrong Eye Billing Errors Found in EMR
Deepika Malik, MD
On Demand Cases, Courses, and Papers
2019
Board-Certified Providers Are Associated With a Reduced Risk of Endophthalmitis After Intravitreal Injections
Geoffrey G. Emerson, MD, PhD, FASRS
Updates from the Field
2021
Inhibition of Complement C3 in GA with NGM621: Phase 1 Study Results
David A. Eichenbaum, MD, FASRS
Updates from the Field
2021
Episode 32 - Change in Management after Vitreous Culture in Endophthalmitis after Intravitreal Injections-Dr. James Vander
Keyvan Koushan, MD, FRCSC
Member Podcasts
2020
Outcomes of Anti-VEGF Treatment for CNV in Fellow Eyes of Previously Treated Patients with Wet AMD
Tarek S. Hassan, MD, FASRS
Updates from the Field
2019